{"id":"W1931293371","doi":"10.1111/j.1468-3083.2011.03984.x","title":"Treatment of palmoplantar psoriasis with infliximab: a randomized, double‐blind placebo‐controlled study","year":2011,"lang":"en","type":"article","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":67,"is_retracted":false,"has_abstract":true,"ca_institutions":"Lynde Centre for Dermatology; Guenther Dermatology Research Centre; Centre de Recherche Dermatologique du Québec Métropolitain; Innovaderm (Canada)","funders":"","keywords":"Medicine; Infliximab; Psoriasis; Placebo; Randomized controlled trial; Internal medicine; Clinical endpoint; Psoriasis Area and Severity Index; Surgery; Gastroenterology; Dermatology; Pathology; Tumor necrosis factor alpha","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006957433,0.000304562,0.001902192,0.0002739712,0.0001253317,0.000002722085,0.0003982468,0.0002379343,0.00006600052],"category_scores_gemma":[0.00005534626,0.0001533913,0.0003847784,0.0001220611,0.0009429479,0.00007337071,0.00008660629,0.0002723611,0.00001108117],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001581487,"about_ca_system_score_gemma":0.00005904389,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002054889,"about_ca_topic_score_gemma":0.00000740848,"domain_scores_codex":[0.994882,0.003427489,0.001142489,0.00020948,0.00006216585,0.0002763293],"domain_scores_gemma":[0.9974267,0.0005956781,0.00166484,0.0001930988,0.00007724771,0.00004246819],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8056282,0.001509562,0.1742943,0.00002682318,0.008163857,0.0002131921,0.005109881,0.00000583298,0.001616346,0.0009902423,0.00009127751,0.002350435],"study_design_scores_gemma":[0.9228837,0.0009069691,0.02848218,0.00005810413,0.004974752,0.01252447,0.0007203954,0.000001787881,0.02818888,0.0002755535,0.0007688052,0.0002143991],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9895934,0.006020314,0.00001772425,0.0003636585,0.0003919749,0.00082656,0.000007814098,0.000008797946,0.002769735],"genre_scores_gemma":[0.998391,0.001069085,0.0001270339,0.00004279015,0.00005077009,0.00001882801,0.000001887865,0.00002016015,0.0002784767],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1458121,"threshold_uncertainty_score":0.6255115,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03670318478321744,"score_gpt":0.2581723549905103,"score_spread":0.2214691702072928,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}